WILLIAM PEACOCK to Length of Stay
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Length of Stay.
Connection Strength
1.564
-
Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
Score: 0.326
-
The effect of a short-stay unit on hospital admission and length of stay in acute heart failure: REDUCE-AHF study. Eur J Intern Med. 2017 May; 40:30-36.
Score: 0.084
-
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1).
Score: 0.084
-
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. J Thromb Thrombolysis. 2016 Nov; 42(4):513-9.
Score: 0.083
-
Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
Score: 0.083
-
Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Hosp Pract (1995). 2016 Aug; 44(3):133-7.
Score: 0.080
-
Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study. BMJ Open. 2016 Feb 25; 6(2):e009746.
Score: 0.079
-
Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
Score: 0.058
-
Primary role of B-type natriuretic peptide across the clinical spectrum: from emergency medicine to transitional care and beyond into the community. Congest Heart Fail. 2011 Jan-Feb; 17(1):8-13.
Score: 0.056
-
Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009; 113(1):12-9.
Score: 0.047
-
Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26.
Score: 0.046
-
Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008 Apr; 25(4):205-9.
Score: 0.046
-
Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events. Ann Emerg Med. 2007 Nov; 50(5):489-96.
Score: 0.043
-
Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology. 2007; 107(1):44-51.
Score: 0.040
-
Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiative. BMJ Open. 2024 06 13; 14(6):e083752.
Score: 0.035
-
Acute Emergency Department management of heart failure. Heart Fail Rev. 2003 Oct; 8(4):335-8.
Score: 0.033
-
Clinical and economic impact of nesiritide. Am J Health Syst Pharm. 2003 Aug 15; 60 Suppl 4:S21-6.
Score: 0.033
-
Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department. Rev Cardiovasc Med. 2002; 3 Suppl 4:S41-8.
Score: 0.030
-
Prehospital electrocardiograms (ECGs) do not improve the process of emergency department care in hospitals with higher usage of ECGs in non-ST-segment elevation myocardial infarction patients. Clin Cardiol. 2009 Dec; 32(12):668-75.
Score: 0.026
-
The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul; 48(1):149-157.
Score: 0.025
-
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2018 01 23; 137(4):354-363.
Score: 0.022
-
Benefit of early discharge among patients with low-risk pulmonary embolism. PLoS One. 2017; 12(10):e0185022.
Score: 0.022
-
Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes. Med J Aust. 2017 Aug 04; 207(5):195-200.
Score: 0.022
-
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703.
Score: 0.022
-
Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry. Chest. 2017 10; 152(4):821-832.
Score: 0.021
-
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
Score: 0.021
-
Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
Score: 0.021
-
A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med. 2014 Jan; 174(1):51-8.
Score: 0.017
-
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009 Nov 25; 302(20):2207-13.
Score: 0.013
-
Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations. Crit Pathw Cardiol. 2009 Sep; 8(3):99-103.
Score: 0.013
-
Venous thromboembolism prophylaxis in hospitalized heart failure patients. J Card Fail. 2008 Mar; 14(2):127-32.
Score: 0.011
-
Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol. 2008 Jan 15; 101(2):231-7.
Score: 0.011
-
ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006 May; 24(3):319-24.
Score: 0.010